SSTR2 and type 2 diabetes mellitus: Additionally, GLP-1 has indirect glucagonostatic effects that may assist in counteracting hyperglucagonaemia in T2DM [16,17], which may be mediated through upregulation of somatostatin secretion via somatostatin-2-receptor (SSTR2) [17].